A. Durack
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
A. Durack has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
N. P. Burrows
Department of Dermatology, Addenbrooke's Hospital, Cambridge, UK
2 shared publicationsA Affleck
1 shared publicationA Ahmed
1 shared publicationA Akhtar
1 shared publicationA Matthews
1 shared publicationA Murphy
1 shared publication
Latest Publications
- 21 August 2021
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 46 (7) , 1384-1386
Infantile‐onset osteoma cutis with pseudopseudohypoparathyroidism
- 21 August 2021
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 46 (7) , 1384-1386
Infantile‐onset osteoma cutis with pseudopseudohypoparathyroidism
- 1 February 2021
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 184 (2) , E29
Congenital bilateral scar-like lesions on the face
- 1 February 2021
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 184 (2) , E29
Congenital bilateral scar-like lesions on the face
- 29 June 2020
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 184 (4) , 731-739
A 10‐year review of surgical management of dermatofibrosarcoma protuberans*
Background Dermatofibrosarcoma protuberans (DFSP) is a rare skin cancer. Standard treatment in the United Kingdom (UK) is either surgical wide local excision (WLE) or Mohs micrographic surgery (MMS). It is unclear which approach has the lower recurrence rate. Objectives We undertook a retrospective comparative review of DFSP surgical management in the UK National Health Service (NHS) in order to define: current surgical practice for primary and recurrent DFSP local recurrence rates for primary DFSP survival outcomes for DFSP. Methods Retrospective clinical case‐note review of patients with histologically‐confirmed DFSP (January 2004–2014) who have undergone surgical treatment. Results Surgical management of 483 primary and 64 recurrent DFSP in 11 plastic surgery and 15 dermatology departments was analysed. Almost 75% of primary DFSP (n=362) were treated with WLE and 20.1% (n=97) with MMS. For recurrent DFSP, 68.7% (n=44) and 23.4% (n=15) underwent WLE and MMS, respectively. Recurrent primary DFSP occurred in 6 patients after WLE and none after MMS. Median follow‐up was 4.8 years [IQR 3.5, 5.8] with 8 reported deaths during the follow‐up analysis period; one confirmed to be DFSP‐related. Conclusions WLE was the commonest surgical modality used to treat DFSP across the UK. The local recurrence rate was very low, occurring only after WLE. Although a prospective RCT may provide more definitive outcomes, in the absence of a clearly superior surgical modality, treatment decisions should be based on patient preference, clinical expertise and cost.
- 29 June 2020
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 184 (4) , 731-739
A 10‐year review of surgical management of dermatofibrosarcoma protuberans*
Background Dermatofibrosarcoma protuberans (DFSP) is a rare skin cancer. Standard treatment in the United Kingdom (UK) is either surgical wide local excision (WLE) or Mohs micrographic surgery (MMS). It is unclear which approach has the lower recurrence rate. Objectives We undertook a retrospective comparative review of DFSP surgical management in the UK National Health Service (NHS) in order to define: current surgical practice for primary and recurrent DFSP local recurrence rates for primary DFSP survival outcomes for DFSP. Methods Retrospective clinical case‐note review of patients with histologically‐confirmed DFSP (January 2004–2014) who have undergone surgical treatment. Results Surgical management of 483 primary and 64 recurrent DFSP in 11 plastic surgery and 15 dermatology departments was analysed. Almost 75% of primary DFSP (n=362) were treated with WLE and 20.1% (n=97) with MMS. For recurrent DFSP, 68.7% (n=44) and 23.4% (n=15) underwent WLE and MMS, respectively. Recurrent primary DFSP occurred in 6 patients after WLE and none after MMS. Median follow‐up was 4.8 years [IQR 3.5, 5.8] with 8 reported deaths during the follow‐up analysis period; one confirmed to be DFSP‐related. Conclusions WLE was the commonest surgical modality used to treat DFSP across the UK. The local recurrence rate was very low, occurring only after WLE. Although a prospective RCT may provide more definitive outcomes, in the absence of a clearly superior surgical modality, treatment decisions should be based on patient preference, clinical expertise and cost.
- 17 September 2018
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 179 (3) , 555-556
Interventional management of hyperhidrosis in secondary care: where do we go from here?
- 17 September 2018
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 179 (3) , 555-556
Interventional management of hyperhidrosis in secondary care: where do we go from here?
- 12 June 2018
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 43 (7) , 860-862
Linear skin defects and microphthalmia
- 12 June 2018
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 43 (7) , 860-862
Linear skin defects and microphthalmia
- 10 April 2017
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 42 (4) , 457-459
Focal dermal hypoplasia: inheritance from father to daughter
- 10 April 2017
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 42 (4) , 457-459
Focal dermal hypoplasia: inheritance from father to daughter